Jasper Therapeutics Inc (JSPR)
22.46
+0.52
(+2.35%)
USD |
NASDAQ |
Nov 05, 16:00
22.46
0.00 (0.00%)
After-Hours: 20:00
Jasper Therapeutics Price to Book Value: 3.383 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 3.305 |
| November 01, 2024 | 3.203 |
| October 31, 2024 | 3.189 |
| October 30, 2024 | 3.277 |
| October 29, 2024 | 3.366 |
| October 28, 2024 | 3.316 |
| October 25, 2024 | 2.944 |
| October 24, 2024 | 2.997 |
| October 23, 2024 | 3.004 |
| October 22, 2024 | 3.024 |
| October 21, 2024 | 2.997 |
| October 18, 2024 | 3.018 |
| October 17, 2024 | 2.986 |
| October 16, 2024 | 2.738 |
| October 15, 2024 | 2.753 |
| October 14, 2024 | 2.497 |
| October 11, 2024 | 2.260 |
| October 10, 2024 | 2.217 |
| October 09, 2024 | 2.274 |
| October 08, 2024 | 2.391 |
| October 07, 2024 | 2.387 |
| October 04, 2024 | 2.421 |
| October 03, 2024 | 2.465 |
| October 02, 2024 | 2.562 |
| October 01, 2024 | 2.605 |
| Date | Value |
|---|---|
| September 30, 2024 | 2.832 |
| September 27, 2024 | 2.836 |
| September 26, 2024 | 2.837 |
| September 25, 2024 | 2.745 |
| September 24, 2024 | 3.281 |
| September 23, 2024 | 3.243 |
| September 20, 2024 | 3.596 |
| September 19, 2024 | 3.600 |
| September 18, 2024 | 3.424 |
| September 17, 2024 | 3.459 |
| September 16, 2024 | 3.454 |
| September 13, 2024 | 3.426 |
| September 12, 2024 | 3.233 |
| September 11, 2024 | 3.110 |
| September 10, 2024 | 3.055 |
| September 09, 2024 | 2.906 |
| September 06, 2024 | 2.805 |
| September 05, 2024 | 2.884 |
| September 04, 2024 | 2.923 |
| September 03, 2024 | 2.888 |
| August 30, 2024 | 3.283 |
| August 29, 2024 | 3.025 |
| August 28, 2024 | 3.004 |
| August 27, 2024 | 3.049 |
| August 26, 2024 | 3.010 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3585
Minimum
Dec 29 2022
7.900
Maximum
Oct 15 2021
2.308
Average
1.693
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.090 |
| Theriva Biologics Inc | 0.0760 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| Price | 22.46 |
| Earnings Yield | -82.80% |
| Market Cap | 339.34M |